Search

The Corporate Transparency Act (CTA) imposes significant new reporting requirements on many small businesses, as of January 1, 2024. The law requires all “reporting companies” to identify their “beneficial owners” and “company applicants” in a report to be filed with the U.S. Treasury Department’s...

As the U.S. seeks to jumpstart a hydrogen economy with the creation of Regional Clean Hydrogen Hubs (H2Hubs), Saul Ewing stands ready to advise clients in the energy, transportation, industrial, manufacturing and agribusiness industries on next steps. The H2Hubs will accelerate the commercial-scale...

With a rapid pace of adoption, artificial intelligence (AI) platforms and applications are becoming widespread in nearly every industry. While these tools unlock great potential, their unchecked use presents many challenges. For example, employees without adequate training could be entering...

Companies planning to develop and commercialize medical devices or diagnostics face a challenging financing, regulatory, reimbursement and liability environment. Saul Ewing attorneys are experienced in helping medical device and diagnostic companies navigate these challenges. Many members of our...

Responsive Service and Real-World Guidance Attorneys in Saul Ewing's Financial Services Practice advise and represent local, community and regional banks; credit unions; and other private and public finance entities in a wide range of transactional and business matters. We provide practical legal...

A key component of a company’s intellectual property strategy is the protection of its industrial designs, including the ornamental features of products, graphical user interfaces, icons and fonts, to combat competitors copying its products. Industrial design protection fills a niche between (and...

Saul Ewing attorneys have significant experience advising a wide variety of clients in the entertainment, music, visual and performing arts industries. Our clients include artists, writers, musicians, models, film, and multi-media production companies, record labels, producers, merchandisers...

The pharmaceutical industry faces a challenging business environment as competition drives down prices, R&D expenses rise, and government scrutiny deepens. However, companies have many options for navigating these challenges, generally by making deals with others in the field, including mergers and...

An Experienced Legal Team for the Entire Life Cycle of a Fund The complexities of forming and managing an investment fund are vast and varied — from changing market trends and investment strategies, to shifting tax and regulatory requirements. Navigating this landscape while maximizing return on...

Guidance Throughout a Shifting Global Landscape Growth and opportunity are driving factors for success in today’s expanding global economy. The prevalence of crossing borders to gain a competitive edge, sustain profitability, maximize investments or realize personal goals has resulted in a critical...

Protecting patents and maximizing their value are paramount to the success of brand pharmaceutical companies and university technology departments, in particular as they relate to generic competitors who file Abbreviated New Drug Applications (ANDAs) under the Hatch-Waxman Act. Saul Ewing’s...

Saul Ewing attorneys counsel boards on both the routine and extraordinary decisions they encounter. We advise public company boards with respect to exchange and federal securities rules. We counsel on: Fiduciary and financial reporting responsibilities Board policies, procedures, governance and...

Debt financing can be an invaluable resource for borrowers when capital is required to fund the needs of a company or an organization that is unable or unwilling to sell equity. Lenders strive to serve the needs of their borrower clients while safeguarding their own interests and ultimately ensuring...

Saul Ewing attorneys provide legal opinions in connection with complex business, financing and real estate transactions involving corporations, limited liability companies (LLCs), limited partnerships (LPs), real estate investment trusts (REITs), statutory and business trusts, and nonprofits. We...

In response to the ongoing challenges to their profits, pharmaceutical and other life sciences companies continue to outsource many specialized services. From R&D to manufacturing – and everything in between – opportunities abound for companies that have the knowledge and expertise to effectively...

Nonprofits contend with the same range of corporate matters and challenges as many for-profit companies, and additionally must follow strict guidelines to maintain their nonprofit tax status. From large hospital organizations to small charities, nonprofits strive to operate efficiently within their...

Saul Ewing’s experienced patent attorneys assist companies and institutions in securing, leveraging, and enforcing commercially valuable intellectual property. From developing patent strategies on a global scale to vigorously asserting and defending patents in court, our team serves as trusted...

Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...

Streamlined Guidance for a Variety of Corporate Matters Public and private companies and nonprofits of all sizes must manage a litany of corporate matters as they strive to operate profitably and efficiently—from initial formation to commercial agreements to various types of joint ventures and...

The Inflation Reduction Act is driving unprecedented investment in renewable energy development in the United States, while the Energy Information Administration forecasts that natural gas development in the United States will continue to grow through 2050. Concerns about climate change are driving...